Ebola Antibody Vaccine Prophylaxis. Phase IIa pilot study evaluating the efficacy of a post-exposure prophylaxis strategy using monoclonal antibodies and a vaccine in high-risk contacts of Ebola virus disease.
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ANRS0006s
Grant search
Key facts
Disease
EbolaStart & end year
20212026Known Financial Commitments (USD)
$551,700Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Research Location
99Lead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Phase 2 clinical trialSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A